Core Laboratories Nv Stock Analysis

Core Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 5.89. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Core Laboratories last dividend was issued on the 3rd of November 2025. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. For more info on Core Laboratories NV please contact Lawrence Bruno at 713 328 2673 or go to https://www.corelab.com.

Core Laboratories Investment Alerts

Core Largest EPS Surprises

View All Earnings Estimates

Core Laboratories Environmental, Social, and Governance (ESG) Scores

Core Stock Institutional Investors

Note, although Core Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Core Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 916.31 M.

Core Profitablity

The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.

Management Efficiency

Core Laboratories has Return on Asset of 0.0497 % which means that on every $100 spent on assets, it made $0.0497 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1226 %, implying that it generated $0.1226 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Core Laboratories' Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.14, whereas Return On Tangible Assets are forecasted to decline to 0.06. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 25.8 M, whereas Total Assets are forecasted to decline to about 553.5 M.

Technical Drivers

As of the 1st of February, Core Laboratories shows the Mean Deviation of 1.97, risk adjusted performance of 0.0782, and Downside Deviation of 2.43. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Core Laboratories Price Movement Analysis

Core Laboratories Insider Trading Activities

Core Laboratories Outstanding Bonds

Core Laboratories Predictive Daily Indicators

Core Laboratories Corporate Filings

Core Laboratories Forecast Models

Core Laboratories' time-series forecasting models are one of many Core Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Core Laboratories Debt to Cash Allocation

Core Laboratories NV has 180.14 M in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. That said, strategic use of leverage may enable Core to fund expansion initiatives and generate superior returns.

Core Laboratories Total Assets Over Time

Core Laboratories Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Core Laboratories uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Core Laboratories Debt Ratio

30.0

It appears about 70% of Core Laboratories' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Core Laboratories' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Core Laboratories, which in turn will lower the firm's financial flexibility.

Core Laboratories Corporate Bonds Issued

Core Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Core Laboratories. By using and applying Core Stock analysis, traders can create a robust methodology for identifying Core entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Core Laboratories NV stock analysis indicators help investors evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock analysis, traders can identify Core Laboratories position entry and exit signals to maximize returns.

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.